Shares of WeightWatchers (WW) are climbing after the company announced a new GLP-1 medication starting at $129 as it seeks to ...

The FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related ...

Shares of WeightWatchers (WW) are climbing after the company announced a compounded GLP-1 medication starting at $129 as it ...

The embattled diet brand said it is adding a compounded weight-loss drug in accordance with FDA rules and manufacturing ...

With the addition of compounded semaglutide [GLP-1], we are expanding our offering to include a clinical weight management ...

WW International, known as WeightWatchers, saw its stock soar on new of its new compounded GLP-1 offering. But analysts say that's only a short-term solution to its ailing business.

WW International (NASDAQ:WW), more commonly known as WeightWatchers, will now offer compounded semaglutide to its ...

WeightWatchers (WW) announced Tuesday that it is now offering off-brand weight loss drugs for one of the cheapest prices in ...

In addition to availability, the cost of weight loss drugs like Wegovy and Zepbound is a major barrier preventing many ...

A recently released negative study by Novo Nordisk (NVO) on the differences between its own semaglutide and liraglutide ...

Shares of WW International, better known as WeightWatchers, soared Tuesday after it said it is offering copycat weight-loss drugs to its members.